Lattuada E.; Cavallaro R.; Serretti A.; Lorenzi C.; Smeraldi E., Tardive dyskinesia and DRD2, DRD3, DRD4, 5-HT2A variants in schizophrenia: an association study with repeated assessment., «INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY», 2004, 7, pp. 1 - 5 [Scientific article]
Serretti A.; Artioli P.; Lorenzi C.; Pirovano A.; Tubazio V.; Zanardi R., The C(-1019)G polymorphism of the 5-HT1A gene promoter and antidepressant response in mood disorders: preliminary findings., «INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY», 2004, 7, pp. 453 - 511 [Scientific article]
Serretti A.; Artioli P., The pharmacogenomics of selective serotonin reuptake inhibitors., «PHARMACOGENOMICS JOURNAL», 2004, 4, pp. 44 - 233 [Scientific article]
Lorenzi C; Tubazio V; Serretti A; De Ronchi D., The Use of DNA Microarray in the Pharmacogenetics of Antidepressants: Guidelines for a Targeted Approach., «CURRENT GENOMICS», 2004, 5, pp. 499 - 508 [Scientific article]
Serretti A; Artioli P; De Ronchi D., The 5-HT2C receptor as a target for mood disorders., «EXPERT OPINION ON THERAPEUTIC TARGETS», 2004, 8, pp. 15 - 23 [Scientific article]
Pae C.U.; Lee K.U.; Han H.; Serretti A.; Jun T.Y., Tumor necrosis factor alpha gene-G308A polymorphism associated with bipolar I disorder in the Korean population., «PSYCHIATRY RESEARCH», 2004, 125, pp. 8 - 65 [Scientific article]
Serretti A., Will pharmacogenetic findings influence our everyday clinical practice?, «CLINICAL NEUROPSYCHIATRY», 2004, 1, pp. 77 - 78 [Scientific article]Open Access
